PMID- 24146326
OWN - NLM
STAT- MEDLINE
DCOM- 20140910
LR  - 20211021
IS  - 1613-7671 (Electronic)
IS  - 0043-5325 (Linking)
VI  - 125
IP  - 23-24
DP  - 2013 Dec
TI  - Clinical outcome after 1 year of cardiac resynchronisation therapy: national 
      results from the European CRT survey.
PG  - 750-4
LID - 10.1007/s00508-013-0429-9 [doi]
AB  - Cardiac resynchronisation therapy (CRT) is an established treatment option for 
      heart failure patients with electromechanical dyssynchrony. Between 2008 and 
      2010, the Heart Failure Association (HFA) and the European Heart Rhythm 
      Association (EHRA) of the European Society of Cardiology (ESC) initiated the 
      European CRT survey to describe the current practice and short-term clinical 
      outcome associated with CRT implantations in 13 countries. One year follow-up 
      data from 150 patients collected in 10 Austrian centres are presented in 
      comparison to the total 1,969 patients enrolled throughout Europe. In most cases 
      (n = 120), CRT-D devices were implanted, while CRT-P devices were used in only 23 
      %. After 12 +/- 3 months, mortality and hospitalisation rates reached 10 and 37 %, 
      respectively. New York Heart Association (NYHA) functional classes improved 
      significantly: NYHA I/II/III/IV were found before implantation in 2/20/71/7 % and 
      after 1 year follow-up in 35/51/9/5 % of the patients, respectively. Left 
      ventricular ejection fraction improved from 27 +/- 8 % to 35 +/- 10 %, left 
      ventricular end-diastolic diameters were reduced from 65 +/- 10 mm to 59 +/- 5 mm. 
      Median NT-proBNP was reduced from 1,886 to 997 pg/ml, QRS duration diminished 
      from 158 +/- 34 to 147 +/- 27 ms. In conclusion, the Austrian data from the CRT 
      survey confirms the efficacy of CRT in heart failure patients, but outlines that 
      these patients still suffer from a high mortality and cardiovascular (CV) 
      hospitalisation rate.
FAU - Dichtl, Wolfgang
AU  - Dichtl W
AD  - Universitatsklinik fur Innere Medizin III/Kardiologie, Medizinische Universitat 
      Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria, wolfgang.dichtl@uki.at.
FAU - Strohmer, Bernhard
AU  - Strohmer B
FAU - Fruhwald, Friedrich
AU  - Fruhwald F
LA  - eng
PT  - Comparative Study
PT  - Journal Article
DEP - 20131022
PL  - Austria
TA  - Wien Klin Wochenschr
JT  - Wiener klinische Wochenschrift
JID - 21620870R
SB  - IM
MH  - Austria/epidemiology
MH  - Cardiac Resynchronization Therapy/*mortality/statistics & numerical data
MH  - Comorbidity
MH  - Europe/epidemiology
MH  - Health Care Surveys
MH  - Heart Failure/*mortality/*prevention & control
MH  - Humans
MH  - Longitudinal Studies
MH  - Population Surveillance
MH  - Prevalence
MH  - Risk Factors
MH  - Survival Rate
MH  - Treatment Outcome
MH  - Ventricular Dysfunction, Left/*mortality/*prevention & control
EDAT- 2013/10/23 06:00
MHDA- 2014/09/11 06:00
CRDT- 2013/10/23 06:00
PHST- 2013/04/05 00:00 [received]
PHST- 2013/09/08 00:00 [accepted]
PHST- 2013/10/23 06:00 [entrez]
PHST- 2013/10/23 06:00 [pubmed]
PHST- 2014/09/11 06:00 [medline]
AID - 10.1007/s00508-013-0429-9 [doi]
PST - ppublish
SO  - Wien Klin Wochenschr. 2013 Dec;125(23-24):750-4. doi: 10.1007/s00508-013-0429-9. 
      Epub 2013 Oct 22.